1. Home
  2. SDGR vs PSEC Comparison

SDGR vs PSEC Comparison

Compare SDGR & PSEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SDGR
  • PSEC
  • Stock Information
  • Founded
  • SDGR 1990
  • PSEC 2004
  • Country
  • SDGR United States
  • PSEC United States
  • Employees
  • SDGR N/A
  • PSEC N/A
  • Industry
  • SDGR Biotechnology: Pharmaceutical Preparations
  • PSEC Finance/Investors Services
  • Sector
  • SDGR Health Care
  • PSEC Finance
  • Exchange
  • SDGR Nasdaq
  • PSEC Nasdaq
  • Market Cap
  • SDGR 1.4B
  • PSEC 1.3B
  • IPO Year
  • SDGR 2020
  • PSEC 2004
  • Fundamental
  • Price
  • SDGR $20.72
  • PSEC $2.74
  • Analyst Decision
  • SDGR Buy
  • PSEC Sell
  • Analyst Count
  • SDGR 8
  • PSEC 1
  • Target Price
  • SDGR $26.75
  • PSEC $2.50
  • AVG Volume (30 Days)
  • SDGR 1.1M
  • PSEC 4.0M
  • Earning Date
  • SDGR 11-11-2025
  • PSEC 11-07-2025
  • Dividend Yield
  • SDGR N/A
  • PSEC 19.78%
  • EPS Growth
  • SDGR N/A
  • PSEC N/A
  • EPS
  • SDGR N/A
  • PSEC N/A
  • Revenue
  • SDGR $237,917,000.00
  • PSEC $719,436,000.00
  • Revenue This Year
  • SDGR $22.73
  • PSEC N/A
  • Revenue Next Year
  • SDGR $19.85
  • PSEC N/A
  • P/E Ratio
  • SDGR N/A
  • PSEC N/A
  • Revenue Growth
  • SDGR 18.59
  • PSEC N/A
  • 52 Week Low
  • SDGR $16.60
  • PSEC $2.57
  • 52 Week High
  • SDGR $28.47
  • PSEC $5.41
  • Technical
  • Relative Strength Index (RSI)
  • SDGR 55.56
  • PSEC 46.48
  • Support Level
  • SDGR $20.04
  • PSEC $2.71
  • Resistance Level
  • SDGR $22.03
  • PSEC $2.81
  • Average True Range (ATR)
  • SDGR 0.97
  • PSEC 0.08
  • MACD
  • SDGR 0.12
  • PSEC 0.02
  • Stochastic Oscillator
  • SDGR 62.01
  • PSEC 65.31

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

About PSEC Prospect Capital Corporation

Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests mainly in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.

Share on Social Networks: